
Xtant Medical Holdings, Inc. – AMEX:XTNT
Xtant Medical Holdings stock price today
Xtant Medical Holdings stock price monthly change
Xtant Medical Holdings stock price quarterly change
Xtant Medical Holdings stock price yearly change
Xtant Medical Holdings key metrics
Market Cap | 51.30M |
Enterprise value | 65.00M |
P/E | -6.67 |
EV/Sales | 1.52 |
EV/EBITDA | -17.37 |
Price/Sales | 1.52 |
Price/Book | 1902.30 |
PEG ratio | 0.13 |
EPS | -0.01 |
Revenue | 101.23M |
EBITDA | -9.22M |
Income | -1.66M |
Revenue Q/Q | 55.34% |
Revenue Y/Y | 60.80% |
Profit margin | -14.7% |
Oper. margin | -11.78% |
Gross margin | 55.81% |
EBIT margin | -11.78% |
EBITDA margin | -9.11% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeXtant Medical Holdings stock price history
Xtant Medical Holdings stock forecast
Xtant Medical Holdings financial statements
$1.5
Potential upside: 130.76%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 20.23M | -2.19M | -10.82% |
---|---|---|---|
Sep 2023 | 25.01M | 9.23M | 36.9% |
Dec 2023 | 28.10M | -4.30M | -15.31% |
Mar 2024 | 27.87M | -4.4M | -15.79% |
Jun 2023 | 65218000 | 34.25M | 52.53% |
---|---|---|---|
Sep 2023 | 92003000 | 37.32M | 40.57% |
Dec 2023 | 92612000 | 41.26M | 44.55% |
Mar 2024 | 93931000 | 46.25M | 49.24% |
Jun 2023 | -2.52M | -394K | 1.95M |
---|---|---|---|
Sep 2023 | -3.83M | -4.65M | 12.84M |
Dec 2023 | -915K | -2.31M | 325K |
Mar 2024 | -5.75M | -674K | 5.17M |
Xtant Medical Holdings alternative data
Aug 2023 | 134 |
---|---|
Sep 2023 | 134 |
Oct 2023 | 134 |
Nov 2023 | 134 |
Dec 2023 | 134 |
Jan 2024 | 134 |
Feb 2024 | 134 |
Mar 2024 | 134 |
Apr 2024 | 134 |
May 2024 | 207 |
Jun 2024 | 207 |
Jul 2024 | 207 |
Xtant Medical Holdings other data
Period | Buy | Sel |
---|---|---|
Jan 2023 | 0 | 8673 |
Nov 2023 | 41670 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | BRANDT KEVIN D officer: Chief Co.. | Common Stock | 41,670 | $1.2 | $49,837 | ||
Sale | NEILS SCOTT C officer: Chief Financial Officer | Common Stock, $0.000001 par value | 8,673 | $0.61 | $5,282 | ||
Sale | BROWNE SEAN E director, officer.. | Common Stock, $0.000001 par value | 51,100 | $0.62 | $31,835 | ||
Sale | BROWNE SEAN E director, officer.. | Common Stock, $0.000001 par value | 80,000 | $0.68 | $54,000 | ||
Purchase | VIZIRGIANAKIS STAVROS G. director | Warrant | 566,214 | $0.48 | $271,783 | ||
Purchase | VIZIRGIANAKIS STAVROS G. director | Common Stock, $0.000001 par value | 2,264,861 | $0.48 | $1,087,133 | ||
Sale | BRANDT KEVIN D officer: Chief Co.. | Common Stock, $0.000001 par value | 4,300 | $0.48 | $2,051 | ||
Sale | NEILS SCOTT C officer: Chief Financial Officer | Common Stock, $0.000001 par value | 1,270 | $0.48 | $605 | ||
Sale | BRANDT KEVIN D officer: Chief Co.. | Common Stock, $0.000001 par value | 18,700 | $0.49 | $9,182 | ||
Sale | NEILS SCOTT C officer: Chief Financial Officer | Common Stock, $0.000001 par value | 5,100 | $0.48 | $2,458 |
Quarter | Transcript |
---|---|
Q1 2024 15 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 1 Apr 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Xtant Medical Holdings stock today?
One share of Xtant Medical Holdings stock can currently be purchased for approximately $0.65.
-
When is Xtant Medical Holdings's next earnings date?
Unfortunately, Xtant Medical Holdings's (XTNT) next earnings date is currently unknown.
-
Does Xtant Medical Holdings pay dividends?
No, Xtant Medical Holdings does not pay dividends.
-
How much money does Xtant Medical Holdings make?
Xtant Medical Holdings has a market capitalization of 51.30M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 57.5% to 91.3M US dollars.
-
What is Xtant Medical Holdings's stock symbol?
Xtant Medical Holdings, Inc. is traded on the AMEX under the ticker symbol "XTNT".
-
What is Xtant Medical Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Xtant Medical Holdings?
Shares of Xtant Medical Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Xtant Medical Holdings's key executives?
Xtant Medical Holdings's management team includes the following people:
- Mr. Sean E. Browne Pres, Chief Executive Officer & Director(age: 59, pay: $1,190,000)
- Mr. Kevin D. Brandt Senior Vice President & Chief Commercial Officer(age: 59, pay: $605,330)
-
How many employees does Xtant Medical Holdings have?
As Jul 2024, Xtant Medical Holdings employs 207 workers, which is 54% more then previous quarter.
-
When Xtant Medical Holdings went public?
Xtant Medical Holdings, Inc. is publicly traded company for more then 15 years since IPO on 1 Jul 2010.
-
What is Xtant Medical Holdings's official website?
The official website for Xtant Medical Holdings is xtantmedical.com.
-
Where are Xtant Medical Holdings's headquarters?
Xtant Medical Holdings is headquartered at 664 Cruiser Lane, Belgrade, MT.
-
How can i contact Xtant Medical Holdings?
Xtant Medical Holdings's mailing address is 664 Cruiser Lane, Belgrade, MT and company can be reached via phone at +40 63880480.
-
What is Xtant Medical Holdings stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Xtant Medical Holdings in the last 12 months, the avarage price target is $1.5. The average price target represents a 130.76% change from the last price of $0.65.
Xtant Medical Holdings company profile:

Xtant Medical Holdings, Inc.
xtantmedical.comAMEX
207
Medical - Devices
Healthcare
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Belgrade, MT 59714
CIK: 0001453593
ISIN: US98420P3082
CUSIP: 98420P308